Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PHASQ | Non-employee Director Stock Option (right to buy) | Award | $0 | +17.5K | $0.00 | 17.5K | May 19, 2022 | Common Stock | 17.5K | $0.84 | Direct | F1 | |
transaction | PHASQ | Restricted Stock Units | Award | $0 | +3.75K | $0.00 | 3.75K | May 19, 2022 | Common Stock | 3.75K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date. |
F2 | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock. |
F3 | The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date. |